Trials / Completed
CompletedNCT00513630
Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
Phase 4 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 304 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the recurrence risk of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease after different antidiabetic drug therapy (glipizide or metformin) by using an double-blind, randomized, parallel control and prospective study The end point of this study is: 1. follow up 3yr 2. recurrence of cardiovascular event 3. death caused by other reasons such as stroke, uremia, blindness and amputation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glipizide | |
| DRUG | Metformin |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2007-08-08
- Last updated
- 2011-04-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00513630. Inclusion in this directory is not an endorsement.